23rd Annual Pharmaceutical and Medical Device Ethics and Compliance Congress
Gary Giampetruzzi, global chair of the Paul Hastings Life Sciences Practice, and BJ D’Avella, leader of the Paul Hastings Life Sciences Consulting Group, will discuss key issues for compliance professionals at the upcoming 23rd Annual Pharmaceutical and Medical Device Ethics and Compliance Congress, October 24-26, in Washington, D.C.
Gary will speak on a panel entitled “CEOs and CCOs Sign on the Compliance Dotted Line — Now What?” with Glenn Leon, incoming fraud section chief, Criminal Division, U.S. Department of Justice, during the exclusive Chief Compliance Officer Roundtable on October 25th at 9:10 a.m.
BJ will participate in a mini summit entitled “You Finished Your Risk Assessment… Now What? Practical Approaches to Making Your Results Meaningful” with Christie Camelio, EQRx’s chief compliance and risk officer, on October 24th at 9:00 a.m.
For more information and to register, visit the PCF website